Annual Report 2000

• Table of Contents (PDF)
• List of Tables and Figures (PDF)
• Mission and Values of the PMPRB (PDF)
• Letter to the Minister (PDF)
• Chairperson's Message (PDF)
• The Patented Medicine Prices Review Board (PDF)
  • Mandate
  • Jurisdiction
  • Members of the Board and Senior Staff
  • Members' Biographies
• Retrospective 2000 (PDF)
  • Re-appointment of the Chairperson and Vice-Chairperson
  • Working Group on Price Review Issues - Update
  • Federal/Provincial/Territorial (F/P/T) Collaboration
  • Communications - Update
  • Other Activities in 2000
• Sales of Drugs in Canada in 2000 (PDF)
  • The Pharmaceutical Industry in Canada
  • Sales of Drugs in Canada
• Trends in Drug Prices and Expenditures (PDF)
  • Prices of Patented Drugs in 2000
  • Price Trends of All Drugs - Patented and Non-Patented
  • Industrial Product Price Index (IPPI)
  • Price Trends in Canada and the United States
  • Relationship of Canadian Prices to Foreign Prices: Past and Present
  • Increased Expenditures on Drugs at the Retail Level
  • Trends in Quantities of Sales of Patented Drug Products
  • Sales by Major Therapeutic Group (ATC class)
• Compliance and Excessive Price Guidelines (PDF)
  • New Patented Drug Products in 2000
  • New Active Substances in 2000
  • Price Review of Patented Drug Products in 2000
  • Update of the 1999 Annual Report
• Enforcement Activities (PDF)
  • Public Hearings
  • Voluntary Compliance Undertakings
• Analysis of Research-and-Development (R&D) Expenditures
  (PDF)
  • Data Sources
  • R&D Expenditures
  • Revenues from Sales
  • R&D-to-Sales Ratios
• Glossary (PDF)
• Table 14: Patented Drug Products Introduced in 2000 (PDF)
• Patented Drug Products for Human Use and Canadian Patentees, January 1, 2000 - December 31, 2000 (PDF)

Return to Annual Reports